Literature DB >> 20515399

Life-threatening complications of vitamin D intoxication due to over-the-counter supplements.

Sara Kaptein1, Arne J Risselada, E Christiaan Boerma, Peter H M Egbers, Peter Nieboer.   

Abstract

INTRODUCTION: Ninety percent of hypercalcemic cases are caused by primary hyperparathyroidism or malignancy. Less frequent causes are granulomatous diseases, drug-induced diseases, and intoxications. CASE REPORT: We present two women with life-threatening hypercalcemia due to the intake of vitamin D-concentrated supplements, which turned out to be 100-1,000 times higher than stated on the label of over-the-counter dietary supplements. Laboratory analysis revealed ionized calcium levels of 4.00 (16.00) and 4.56 mmol/L (18.24 mg/dL) with vitamin D(25) concentrations of 1,372 and 644 nmol/L, respectively. Apart from a patient with general symptoms of hypercalcemia, a case of refractory status epilepticus after correction of serum calcium levels, and in need of prolonged ICU treatment, is described.
CONCLUSION: Initial drug-taking history in the presented cases did not reveal the use of over-the-counter supplements, which underlines the importance of a thorough evaluation of (non-)prescribed medication. Moreover, these supplements may contain higher levels of vitamin D than the label states. As a result, hypercalcemia may be an underlying cause for life-threatening complications, including a well-documented refractory status epilepticus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515399     DOI: 10.3109/15563650.2010.486382

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  10 in total

1.  Use of vitamin D drops leading to kidney failure in a 54-year-old man.

Authors:  Bourne L Auguste; Carmen Avila-Casado; Joanne M Bargman
Journal:  CMAJ       Date:  2019-04-08       Impact factor: 8.262

Review 2.  Vitamin D in the new millennium.

Authors:  Sunil J Wimalawansa
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

3.  Vitamin D deficiency remains prevalent despite increased laboratory testing in New South Wales, Australia.

Authors:  Paul Quaggiotto; Huy Tran; Marie Bhanugopan
Journal:  Singapore Med J       Date:  2014-05       Impact factor: 1.858

Review 4.  A review of the growing risk of vitamin D toxicity from inappropriate practice.

Authors:  Peter N Taylor; J Stephen Davies
Journal:  Br J Clin Pharmacol       Date:  2018-04-16       Impact factor: 4.335

5.  Dosing error with over-the-counter vitamin D supplement: a risk for vitamin D toxicity in infants.

Authors:  Kumaravel Rajakumar; Evelyn Cohen Reis; Michael F Holick
Journal:  Clin Pediatr (Phila)       Date:  2012-04-05       Impact factor: 1.168

Review 6.  Vitamin D safety and requirements.

Authors:  Francisco J A de Paula; Clifford J Rosen
Journal:  Arch Biochem Biophys       Date:  2011-12-09       Impact factor: 4.013

7.  Disparity in cholecalciferol content of commercial preparations available in India.

Authors:  Rajesh Khadgawat; Rekha Ramot; K M Chacko; R K Marwaha
Journal:  Indian J Endocrinol Metab       Date:  2013-11

8.  Vitamin D toxicity in a pediatric toxicological referral center; a cross-sectional study from Iran.

Authors:  Fariba Farnaghi; Hossein Hassanian-Moghaddam; Nasim Zamani; Narges Gholami; Latif Gachkar; Maryam Hosseini Yazdi
Journal:  BMC Pediatr       Date:  2020-07-20       Impact factor: 2.125

9.  Exogenous intoxication by non-prescribed use of vitamin D, a case report.

Authors:  Ana Laura Teodoro de Paula; Wemerson Philipe Ferreira Gonzaga; Lucas Martins Oliveira; Taciana Carla Maia Feibelmann; Juliana Markus
Journal:  BMC Geriatr       Date:  2020-06-24       Impact factor: 3.921

Review 10.  How Much Vitamin D is Too Much? A Case Report and Review of the Literature.

Authors:  Sara De Vincentis; Antonino Russo; Marta Milazzo; Amedeo Lonardo; Maria C De Santis; Vincenzo Rochira; Manuela Simoni; Bruno Madeo
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2021       Impact factor: 2.895

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.